Colestipol hydrochloride

Receptor-associated protein (RAP) is a molecular chaperone for low-density lipoprotein receptor-related protein (LRP), which plays a key role in cholesterol metabolism. The lipoprotein receptor-related protein (LRP) is an endocytic receptor for

Receptor-associated protein (RAP) is a molecular chaperone for low-density lipoprotein receptor-related protein (LRP), which plays a key role in cholesterol metabolism. The lipoprotein receptor-related protein (LRP) is an endocytic receptor for

Receptor-associated protein (RAP) is a molecular chaperone for low-density lipoprotein receptor-related protein (LRP), which plays a key role in cholesterol metabolism. The lipoprotein receptor-related protein (LRP) is an endocytic receptor for

Receptor-associated protein (RAP) is a molecular chaperone for low-density lipoprotein receptor-related protein (LRP), which plays a key role in cholesterol metabolism. The lipoprotein receptor-related protein (LRP) is an endocytic receptor for

Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC50 of 230 pM. Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist.

Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC50 of 230 pM. Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

InformationSBC-115076 SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 ( PCSK9 ) antagonist.TargetsPCSK9In vitroIn HepG2 cells, SBC-115076 increases the uptake of Fluorescent Dil-LDL.In vivoIn mice that are fed high

InformationSBC-115076 SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 ( PCSK9 ) antagonist.TargetsPCSK9In vitroIn HepG2 cells, SBC-115076 increases the uptake of Fluorescent Dil-LDL.In vivoIn mice that are fed high

InformationSBC-115076 SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 ( PCSK9 ) antagonist.TargetsPCSK9In vitroIn HepG2 cells, SBC-115076 increases the uptake of Fluorescent Dil-LDL.In vivoIn mice that are fed high

InformationSBC-115076 SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 ( PCSK9 ) antagonist.TargetsPCSK9In vitroIn HepG2 cells, SBC-115076 increases the uptake of Fluorescent Dil-LDL.In vivoIn mice that are fed high

A non-peptide antagonist of PAR1 blocks binding of haTRAP (IC₅₀ = 70 nM) as well as platelet aggregation induced by either haTRAP or &alpha-thrombin (IC₅₀ = 0.3 and 3 &microM, respectively) has no activity against PAR2,